A Randomized, placebo-controlled pilot trial to investigate the safety and efficacy of MLC901 (NEUROAID IITM) in adults following mild or moderate traumatic brain injury

Authors
Category Primary study
JournalJOURNAL OF THE NEUROLOGICAL SCIENCES
Year 2017
This article has no abstract
Epistemonikos ID: a63dabc64505b8cd4594a86bf11c3802fefd8c69
First added on: Feb 08, 2025